Myriad Genetics Shares Drop as CEO Resigns, Sales Fall Short

(Bloomberg) -- Myriad Genetics Inc. shares plunged after the DNA-testing company said its top executive would depart amid a steep drop in sales.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.